| Title |
Current Concepts About Chromium Supplementation in Type 2 Diabetes and Insulin Resistance
|
|---|---|
| Published in |
Current Diabetes Reports, March 2010
|
| DOI | 10.1007/s11892-010-0097-3 |
| Pubmed ID | |
| Authors |
Zhong Q. Wang, William T. Cefalu |
| Abstract |
Chromium has been established to be an essential trace element in mammals in regard to maintenance of normal carbohydrate metabolism. Studies that provided chromium to human subjects in documented deficiency states noted improved glucose levels. However, controversy exists as to whether dietary supplementation with chromium should be routinely recommended in subjects without documented deficiencies. Over the recent past, several well-designed clinical trials have provided evidence in favor of and against a beneficial effect of chromium. It appears that across all subject phenotypes (eg, lean and obese, insulin sensitive and insulin resistant), a consistent significant and beneficial effect of chromium may not be observed. Specifically, recent data fail to demonstrate significant improvement in carbohydrate metabolism in individuals with metabolic syndrome, impaired glucose tolerance, or consistently in individuals with type 2 diabetes. However, patient selection may be an important factor in determining clinical response, as it was concluded that a clinical response to chromium (ie, decreased glucose and improved insulin sensitivity) may be more likely in insulin-resistant individuals with type 2 diabetes who have more elevated fasting glucose and hemoglobin A(1c) levels. |
Mendeley readers
The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | <1% |
| Netherlands | 1 | <1% |
| Australia | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 145 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 54 | 36% |
| Student > Master | 22 | 15% |
| Researcher | 14 | 9% |
| Student > Postgraduate | 10 | 7% |
| Student > Ph. D. Student | 8 | 5% |
| Other | 22 | 15% |
| Unknown | 19 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 30% |
| Agricultural and Biological Sciences | 23 | 15% |
| Nursing and Health Professions | 14 | 9% |
| Biochemistry, Genetics and Molecular Biology | 12 | 8% |
| Environmental Science | 7 | 5% |
| Other | 29 | 19% |
| Unknown | 20 | 13% |
Attention Score in Context
This research output has an Altmetric Attention Score of 53. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 November 2020.
All research outputs
#796,874
of 25,542,788 outputs
Outputs from Current Diabetes Reports
#27
of 1,058 outputs
Outputs of similar age
#2,263
of 102,746 outputs
Outputs of similar age from Current Diabetes Reports
#2
of 12 outputs
Altmetric has tracked 25,542,788 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,058 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 102,746 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.